SEARCH

SEARCH BY CITATION

References

  • Ådén U., Herlenius E., Tang L. Q. and Fredholm B. B. (2000) Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain. Pediatr. Res. 48, 177183.
  • Ådén U., Leverin A. L., Hagberg H. and Fredholm B. B. (2001) Adenosine A (1) receptor agonism in the immature rat brain and heart. Eur. J. Pharmacol. 426, 185192.
  • Aldridge A., Bailey J. and Neims A. H. (1981) The disposition of caffeine during and after pregnancy. Semin. Perinatol. 5, 310314.
  • Ammon H. P. (1991) Biochemical mechanism of caffeine tolerance. Arch. Pharmacol. 324, 261267.
  • Andresen B. T., Gillespie D. G., Mi Z., Dubey R. K. and Jackson E. K. (1999) Role of adenosine A(1) receptors in modulating extracellular adenosine levels. J. Pharmacol. Exp. Ther. 291, 7680.
  • Arnaud M. J. (1987) The pharmacology of caffeine. Prog. Drug Res. 31, 273313.
  • Böhm S. K., Grady E. F. and Bunnett N. W. (1997) Regulatory mechanisms that modulate signalling by G protein-coupled receptors. Biochem. J. 322, 118.
  • Bona E., Aden U., Fredholm B. B. and Hagberg H. (1995) The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate. Pediatr. Res. 38, 312318.
  • Boulenger J. P., Patel J., Post R. M., Parma A. M. and Marangos P. J. (1983) Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci. 32, 11351142.
  • Brazier J. L., Ritter J., Berland M., Khenfer D. and Faucon G. (1983) Pharmacokinetics of caffeine during and after pregnancy. Dev. Pharmacol. Ther. 6, 315322.
  • Bruns R. F., Daly J. W. and Snyder S. H. (1980) Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc. Natl. Acad. Sci. USA 77, 55475551.
  • Carrier O., Pons G., Rey E., Richard M. O., Moran C., Badoual J. and Olive G. (1988) Maturation of caffeine metabolic pathways in infancy. Clin. Pharmacol. Ther. 44, 145151.
  • Cheng Y. and Prusoff W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 30993108.
  • Choi O. H., Shamim M. T., Padgett W. L. and Daly J. W. (1988) Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 43, 387398.
  • Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal. Biochem. 162, 156159.DOI: 10.1006/abio.1987.9999
  • Chou D. T., Khan S., Forde J. and Hirsh K. R. (1985) Caffeine tolerance: behavioral, electrophysiological and neurochemical evidence. Life Sci. 36, 23472358.
  • Conlay L. A., Conant J. A., DeBros F. and Wurtman R. (1997) Caffeine alters plasma adenosine levels. Nature 389, 136.
  • Etzel B. A. and Guillet R. (1994) Effects of neonatal exposure to caffeine on adenosine A1 receptor ontogeny using autoradiography. Brain Res. Dev. Brain Res. 82, 223230.
  • Fastbom J. and Fredholm B. B. (1990) Effects of long-term theophylline treatment on adenosine A1-receptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G proteins. Brain. Res. 507, 195199.
  • Finn I. B. and Holtzman S. G. (1987) Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity. Psychopharmacology. (Berl) 93, 428434.
  • Finn I. B. and Holtzman S. G. (1988) Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats. Life Sci. 42, 24752482.
  • Fredholm B. B. (1980) Theophylline actions on adenosine receptors. Eur. J. Respir. Dis. Suppl. 109, 2936.
  • Fredholm B. B. (1982) Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol. Scand. 115, 283286.
  • Fredholm B. B. (1995) Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76, 93101.
  • Fredholm B. B. and Lindstrom K. (1999) Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A (2A) receptors. Eur. J. Pharmacol. 380, 197202.
  • Fredholm B. B., Battig K., Holmen J., Nehlig A. and Zvartau E. E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83133.
  • Gilbert J. and Scott P. (2000) Food additives and contaminants started in 1984. Food Addit. Contam 17, 1.
  • Guillet R. and Kellogg C. (1991) Neonatal exposure to therapeutic caffeine alters the ontogeny of adenosine A1 receptors in brain of rats. Neuropharmacology 30, 489496.
  • Hettinger-Smith B. D., Leid M. and Murray T. F. (1996) Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells. J. Neurochem. 67, 19211930.
  • Holtzman S. G., Mante S. and Minneman K. P. (1991) Role of adenosine receptors in caffeine tolerance. J. Pharmacol. Exp. Ther. 256, 6268.
  • Ikeda G. J., Sapienza P. P., McGinnis M. L., Bragg L. E., Walsh J. J. and Collins T. F. (1982) Blood levels of caffeine and results of fetal examination after oral administration of caffeine to pregnant rats. J.Appl. Toxicol. 2, 307314.
  • Jacobson K. A., Von Lubitz D. K., Daly J. W. and Fredholm B. B. (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol. Sci. 17, 108113.
  • Johansson B., Ahlberg S., Van Der Ploeg I., Brene S., Lindefors N., Persson H. and Fredholm B. B. (1993) Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 347, 407414.
  • Johansson B., Georgiev V., Lindstrom K. and Fredholm B. B. (1997) A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment. Brain Res. 762, 153164.
  • Kaplan G. B., Greenblatt D. J., Kent M. A. and Cotreau-Bibbo M. M. (1993) Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J. Pharmacol. Exp. Ther. 266, 15631572.
  • Kessler M., Terramani T., Lynch G. and Baudry M. (1989) A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists. J. Neurochem. 52, 13191328.
  • Kimmel C. A., Kimmel G. L., White C. G., Grafton T. F., Young J. F. and Nelson C. J. (1984) Blood flow changes and conceptal development in pregnant rats in response to caffeine. Fundam. Appl. Toxicol. 4, 240247.
  • Knutti R., Rothweiler H. and Schlatter C. (1981) Effect of pregnancy on the pharmacokinetics of caffeine. Eur. J. Clin. Pharmacol. 21, 121126.
  • Lau C. E. and Falk J. L. (1995) Dose-dependent surmountability of locomotor activity in caffeine tolerance. Pharmacol. Biochem. Behav. 52, 139143.
  • Von Lubitz D. K. (1999) Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 371, 85102.
  • Lupica C. R., Berman R. F. and Jarvis M. F. (1991) Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic study. Synapse 9, 95102.
  • Meng F., Xie G. X., Chalmers D., Morgan C., Watson S. J. Jr and Akil H. (1994) Cloning and characterization of a pharmacologically distinct A1 adenosine receptor from guinea pig brain. Brain Res. Mol. Brain Res. 26, 143155.
  • Morgan K. J., Stults V. J. and Zabik M. E. (1982) Amount and dietary sources of caffeine and saccharin intake by individuals ages 5–18 years. Regul. Toxicol. Pharmacol. 2, 296307.
  • Murray T. F. (1982) Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur. J. Pharmacol. 82, 113114.
  • Narod S. A., De Sanjose S. and Victora C. (1991) Coffee during pregnancy: a reproductive hazard? Am. J. Obstet. Gynecol. 164, 11091114.
  • Navarro A., Zapata R., Canela E. I., Mallol J., Lluis C. and Franco R. (1999) Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line. Brain Res. 816, 4757.
  • Nehlig A. (1999) Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci. Biobehav. Rev. 23, 563576.
  • Nehlig A. and Debry G. (1994) Consequences on the newborn of chronic maternal consumption of coffee during gestation and lactation: a review. J. Am. Coll. Nutr. 13, 621.
  • Olah M. E. and Stiles G. L. (1995) Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35, 581606.
  • Palmer T. M. and Stiles G. L. (1997) Structure-function analysis of inhibitory adenosine receptor regulation. Neuropharmacology 36, 11411147.
  • Patwardhan R. V., Desmond P. V., Johnson R. F. and Schenker S. (1980) Impaired elimination of caffeine by oral contraceptive steroids. J.Lab. Clin. Med. 95, 603608.
  • Pearlman S. A., Duran C., Wood M. A., Maisels M. J. and Berlin C. M. Jr (1989) Caffeine pharmacokinetics in pre-term infants older than 2 weeks. Dev. Pharmacol. Ther. 12, 6569.
  • Ralevic V. and Burnstock G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413492.
  • Ren H. and Stiles G. L. (1994) Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing. J. Biol. Chem. 269, 31043110.
  • Ribeiro J. A. (1999) Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur. J. Pharmacol. 375, 101113.
  • Rivkees S. A. (1995) The ontogeny of cardiac and neural A1 adenosine receptor expression in rats. Brain Res. Dev. Brain Res. 89, 202213.
  • Sanders R. C. and Murray T. F. (1988) Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain. Neuropharmacology 27, 757760.
  • Sinton C. M., Valatx J. L. and Jouvet M. (1981) Increased sleep time in the offspring of caffeine-treated dams from two inbred strains of mice. Neurosci. Lett. 24, 169174.
  • Snyder S. H., Katims J. J., Annau Z., Bruns R. F. and Daly J. W. (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl. Acad. Sci. USA 38, 32603264.
  • Somani S. M. and Gupta P. (1988) Caffeine: a new look at an age-old drug. Int. J. Clin. Pharmacol. Ther. Toxicol. 26, 521533.
  • Svenningsson P., Le Moine C., Fisone G. and Fredholm B. B. (1999a) Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog. Neurobiol. 59, 355396.
  • Svenningsson P., Nomikos G. G. and Fredholm B. B. (1999b) The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J. Neurosci. 19, 40114022.
  • Tanaka H., Nakazawa K., Arima M. and Iwasaki S. (1984) Caffeine and its dimethylxanthines and fetal cerebral development in rat. Brain Dev. 6, 355361.
  • Vendite D., Sanz J. M., Lopez-Alanon D. M., Vacas J., Andres A. and Ros M. (1998) Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells. Neurochem. Res. 23, 211218.
  • Weaver D. R. (1996) A1-adenosine receptor gene expression in fetal rat brain. Brain Res. Dev. Brain Res. 94, 205223.
  • Wilkinson J. M. and Pollard I. (1993) Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine. Brain Res. Dev. Brain Res. 75, 193199.
  • Yoneyama Y., Suzuki S., Sawa R., Otsubo Y., Power G. G. and Araki T. (2000a) Plasma adenosine levels increase in women with normal pregnancies. Am. J. Obstet. Gynecol. 182, 12001203.
  • Yoneyama Y., Suzuki S., Sawa R., Takeuchi T., Kobayashi H., Takei R., Kiyokawa Y., Otsubo Y., Hayashi Z. and Araki T. (2000b) Changes in plasma adenosine concentrations during normal pregnancy. Gynecol. Obstet. Invest. 50, 145148.
  • Zhou Q. Y., Li C., Olah M. E., Johnson R. A., Stiles G. L. and Civelli O. (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89, 74327436.